Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.5 USD | 0.00% | 0.00% | -14.81% |
Mar. 13 | RBC Raises Price Target on NeueHealth to $8 From $7 on Improving Liquidity, Keeps Sector Perform Rating | MT |
Mar. 06 | Transcript : NeueHealth, Inc., Q4 2023 Earnings Call, Mar 06, 2024 |
Financials (USD)
Sales 2023 | 1.16B | Sales 2024 * | 1.01B | Capitalization | 52.14M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 | 0.05 x |
Net Debt 2023 * | 254M | Net cash position 2024 * | 234M | EV / Sales 2024 * | -0.18 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 2,840 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 85.61% |
Latest transcript on NeueHealth, Inc.
Current month | -16.77% | ||
1 month | -15.20% | ||
3 months | +23.57% | ||
6 months | +8.70% | ||
Current year | -14.81% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Sheehy
FOU | Founder | 66 | 15-08-06 |
George Mikan
CEO | Chief Executive Officer | 52 | 18-12-31 |
Jay Matushak
DFI | Director of Finance/CFO | 50 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
George Mikan
CEO | Chief Executive Officer | 52 | 18-12-31 |
Jeff Immelt
BRD | Director/Board Member | 68 | 20-04-22 |
Robert Sheehy
FOU | Founder | 66 | 15-08-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 8 M€ | +9.75% | - | |
0.00% | 142 M€ | +6.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 6.5 | 0.00% | 6 201 |
24-03-27 | 6.5 | +3.17% | 14,349 |
24-03-26 | 6.3 | -4.55% | 6,364 |
24-03-25 | 6.6 | +0.61% | 3,998 |
24-03-22 | 6.56 | +0.92% | 12,093 |
Delayed Quote Nyse, March 28, 2024 at 03:36 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-14.81% | 52.14M | |
+18.06% | 82.58B | |
+12.07% | 53.45B | |
+4.07% | 49.27B | |
+13.20% | 42.03B | |
+22.80% | 40.35B | |
+7.55% | 31.7B | |
-1.23% | 29.47B | |
-16.25% | 26.12B | |
+28.68% | 24.84B |